» Articles » PMID: 36914996

Rural-Urban Disparities in Receipt of Surgery for Potentially Resectable Non-Small Cell Lung Cancer

Overview
Journal J Surg Res
Specialty General Surgery
Date 2023 Mar 14
PMID 36914996
Authors
Affiliations
Soon will be listed here.
Abstract

Introduction: Access to cancer care, especially surgery, is limited in rural areas. However, the specific reasons rural patient populations do not receive surgery for non-small cell lung cancer (NSCLC) is unknown. We investigated geographic disparities in reasons for failure to receive guideline-indicated surgical treatment for patients with potentially resectable NSCLC.

Methods: The National Cancer Database was used to identify patients with clinical stage I-IIIA (N0-N1) NSCLC between 2004 and 2018. Patients from rural areas were compared to urban areas, and the reason for nonreceipt of surgery was evaluated. Adjusted odds of (1) primary nonsurgical management, (2) surgery being deemed contraindicated due to risk, (3) surgery being recommended but not performed, and (4) overall failure to receive surgery were determined.

Results: The study included 324,785 patients with NSCLC with 42,361 (13.0%) from rural areas. Overall, 62.4% of patients from urban areas and 58.8% of patients from rural areas underwent surgery (P < 0.001). Patients from rural areas had increased odds of (1) being recommended primary nonsurgical management (adjusted odds ratio [aOR]: 1.14, 95% confidence interval [CI]: 1.05-1.23), (2) surgery being deemed contraindicated due to risk (aOR: 1.19, 95% CI: 1.07-1.33), (3) surgery being recommended but not performed (aOR: 1.13, 95% CI: 1.01-1.26), and (4) overall failure to receive surgery (aOR: 1.21, 95% CI: 1.13-1.29; all P < 0.001).

Conclusions: There are geographic disparities in the management of NSCLC. Rural patient populations are more likely to fail to undergo surgery for potentially resectable disease for every reason examined.

Citing Articles

Rurality predisposes departure from gold-standard care, leading to delayed or accelerated access to surgery: insights from a scoping review.

Ebrahim A, Sinha S, Adedipe I, Ahmad A, Amyotte M, Yang L Can J Surg. 2025; 68(1):E17-E31.

PMID: 39753325 PMC: 11684926. DOI: 10.1503/cjs.000124.


Disparity of the Treatment of Unresectable Non-small Cell Lung Cancer Regarding Chemotherapy: A Systematic Review and Meta-Analysis.

Ohta R, Sano C Cureus. 2024; 16(5):e60635.

PMID: 38899245 PMC: 11185987. DOI: 10.7759/cureus.60635.


Evaluation of Nationwide Trends in Nodal Sampling Guideline Adherence for Gastric Cancer: 2005-2017.

Mahenthiran A, Logan C, Janczewski L, Valukas C, Warwar S, Silver C J Surg Res. 2023; 291:514-526.

PMID: 37540969 PMC: 10529819. DOI: 10.1016/j.jss.2023.07.011.

References
1.
Cykert S, Phifer N . Surgical decisions for early stage, non-small cell lung cancer: which racially sensitive perceptions of cancer are likely to explain racial variation in surgery?. Med Decis Making. 2003; 23(2):167-76. DOI: 10.1177/0272989X03251244. View

2.
Veenstra J, Khalid T, Stewart K, Valji A, Bedard E, Johnson S . Automatic Referral for Potential Thoracic Malignant Diseases Detected on Computed Tomographic Scan. Ann Thorac Surg. 2020; 110(6):1869-1873. DOI: 10.1016/j.athoracsur.2020.05.040. View

3.
Johnson A, Hines R, Johnson 3rd J, Bayakly A . Treatment and survival disparities in lung cancer: the effect of social environment and place of residence. Lung Cancer. 2014; 83(3):401-7. DOI: 10.1016/j.lungcan.2014.01.008. View

4.
Hua X, Ward K, Gillespie T, Lipscomb J, Goodman M . Non-small cell lung cancer treatment receipt and survival among African-Americans and whites in a rural area. J Community Health. 2013; 39(4):696-705. DOI: 10.1007/s10900-013-9813-7. View

5.
Chadha A, Ganti A, Sohi J, Sahmoun A, Mehdi S . Survival in untreated early stage non-small cell lung cancer. Anticancer Res. 2005; 25(5):3517-20. View